Results showed that IL-33 was downregulated in the GC group vs. HC (0.53 ± 0.30; p < 0.001) (Figure 6a), while ST2 L was upregulated in gastric cancer patients (3.12 ± 2.30; p < 0.05) (Figure 6b). This evidence concerns the gene IL33 and gastric cancer.